Morgan Stanley says this pharma stock can rally more than 60% thanks to its narcolepsy treatment

This stock could be at the forefront of a leading narcolepsy treatment that can send its shares soaring, according to Morgan Stanley.

Sep 21, 2024 - 00:00
 0  18
Morgan Stanley says this pharma stock can rally more than 60% thanks to its narcolepsy treatment
This stock could be at the forefront of a leading narcolepsy treatment that can send its shares soaring, according to Morgan Stanley.